Zeo ScientifiX (ZEOX) Net Equity Issued and Repurchased (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Net Equity Issued and Repurchased of $650000.0 for Q2 2026, down 50.0% quarter-over-quarter from $1.3 million in Q1 2026.
Zeo ScientifiX (ZEOX) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Net Equity Issued and Repurchased history runs 11 years deep, the most recent figure standing at $650000.0 for Q2 2026.
- In Q2 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $650000.0; the TTM figure through Apr 2026 stood at $2.0 million (changed N/A YoY), while the FY2025 annual figure was $300000.0, down 40.0% from the prior year.
- Net Equity Issued and Repurchased for Q2 2026 stood at $650000.0, down from $1.3 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $6.6 million in Q4 2022, with the low at $100000.0 in Q1 2023.
- The 3-year median for Net Equity Issued and Repurchased is $640000.0 (2022), against an average of $1.6 million.
- The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased jumped 2106.67% in 2022, then plunged 75.0% in 2023.
- Zeo ScientifiX's Net Equity Issued and Repurchased stood at $6.6 million in 2022, then plunged by 98.49% to $100000.0 in 2023, then surged by 550.0% to $650000.0 in 2026.
- Business Quant data shows ZEOX's Net Equity Issued and Repurchased at $650000.0 in Q2 2026, $1.3 million in Q1 2026, and $100000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 650,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 650,000.00 |
| Apr 30, 2026 | 650,000.00 |
| Jan 31, 2026 | 1.30 Mn |
| Jan 31, 2026 | 1.30 Mn |
| Jan 31, 2023 | 100,000.00 |
| Jan 31, 2023 | 100,000.00 |
| Oct 31, 2022 | 6.62 Mn |
| Oct 31, 2022 | 6.62 Mn |
| Apr 30, 2022 | 630,000.00 |
| Apr 30, 2022 | 630,000.00 |
| Jan 31, 2022 | 400,000.00 |
| Jan 31, 2022 | 400,000.00 |
| Oct 31, 2021 | 300,000.00 |
| Oct 31, 2021 | 300,000.00 |
| Jul 31, 2021 | 631,020.00 |
| Jul 31, 2021 | 631,020.00 |
| Apr 30, 2021 | 535,000.00 |
| Apr 30, 2021 | 535,000.00 |
| Jan 31, 2021 | 40,000.00 |
| Jan 31, 2021 | 40,000.00 |